ZLAB — Zai Lab Ltd
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1704292 ·
China
Last close
$18.45
Market Cap
$2.07B
52W High
$25.28
52W Low
$17.10
ADV30
821,054
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 99,611,000 | 61,276,000 | -69,279,000 | -51,016,000 | 1,095,737,000 | 651,316,000 | 433,756,000 |
| Dec 2025 | 127,597,000 | 65,266,000 | -68,264,000 | -50,409,000 | 1,172,384,000 | 679,573,000 | 456,884,000 |
| Sep 2025 | 116,095,000 | 69,212,000 | -47,968,000 | -35,963,000 | 1,158,940,000 | 717,155,000 | 398,995,000 |
| Jun 2025 | 109,977,000 | 66,757,000 | -51,045,000 | -40,727,000 | 1,164,101,000 | 732,159,000 | 372,366,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-101,002,000
Investing CF
$-40,555,000
Financing CF
$34,785,000
CapEx
$-31,847,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.70
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-2,679,636,000
Inventory
$85,961,000
Receivables
$61,998,000
ST Investments
$10,000,000
EBIT TTM
$-173,942,000
Pretax Income TTM
$-179,602,000
Interest Exp TTM
$5,660,000
Analysts
12
Yahoo Snapshot (yfinance, live)
Total Revenue
$453,280,000
EBITDA
$-227,012,000
Free Cash Flow
$-73,355,376
Enterprise Value
$20,479,832,064
Total Cash
$661,315,968
Total Debt
$231,908,992
Shares Out
112,354,858
Trailing EPS
$-1.70
Book Value
$6.47
ROE
-24.2%
ROA
-13.4%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 460,156,000 | -223,572,000 | -175,537,000 | 1,172,384,000 | 456,884,000 | — | -150,789,000 |
| Dec 2024 | 398,988,000 | -273,947,000 | -257,103,000 | 1,185,753,000 | 344,855,000 | — | -214,869,000 |
| Dec 2023 | 266,719,000 | -374,140,000 | -334,620,000 | 1,036,295,000 | 240,177,000 | — | -198,178,000 |
| Dec 2022 | 215,040,000 | -392,886,000 | -443,286,000 | 1,220,140,000 | 174,545,000 | — | -367,642,000 |
TTM Snapshot
Revenues TTM
$102,265,000
NetIncome TTM
$-41,671,000
OpCashFlow TTM
$0
Assets (Latest)
$1,185,753,000
Forward EPS
$-1.75
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PHVS | Pharvaris N.V. | $2.09B | $29.88 | — |
| TRVI | Trevi Therapeutics, Inc. | $2.04B | $14.38 | — |
| HCM | HUTCHMED (China) Ltd | $2.02B | $11.75 | — |
| BHC | Bausch Health Companies Inc. | $2.02B | $5.40 | — |
| TYRA | Tyra Biosciences, Inc. | $2.00B | $33.59 | — |
News headlines (Yahoo Finance, 1h cache)
Zai Lab Announces Changes to Senior Leadership Team
2026-05-21 22:09 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Lower in Monday Trading
2026-05-18 14:44 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Fall Sharply in Friday Trading
2026-05-15 14:38 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Open Week Lower in Monday Trading
2026-05-11 14:37 · Yahoo
Zai Lab Limited (NASDAQ:ZLAB) Analysts Are Cutting Their Estimates: Here's What You Need To Know
2026-05-11 13:58 · Yahoo
Zai Lab Receives U.S. FDA Fast Track Designation for Zocilurtatug Pelitecan (Zoci), a DLL3-Targeting ADC, for Treatment of Extrapulmonary Neuroendocrine Carcinomas (epNECs)
2026-05-11 11:00 · Yahoo
Zai Lab Q1 Earnings Call Highlights
2026-05-09 09:05 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Edge Higher Friday
2026-05-08 14:45 · Yahoo
Zai Lab Limited (ZLAB) Reports Q1 Earnings: What Key Metrics Have to Say
2026-05-07 13:30 · Yahoo
Zai Lab Announces First Quarter 2026 Financial Results and Recent Corporate Updates
2026-05-07 10:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.